—Mkt Cap: —P/E: —
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astig…
Industry Peers
Health Care Technologyloading…
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value74.88M USD
Revenue (TTM)57.70M USD
Gross Profit27.12M USD
Net Income (TTM)-34.28M USD
Revenue/Share4.787 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees150
CountryUS
SectorHealth Care
IndustryHealth Care Technology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.38
PEG—
EV/EBITDA-6.32
EV/Revenue1.30
P/S1.25
P/B6.67
EPS (TTM)-0.55
EPS (Forward)-0.71
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin46.41%
Oper. Margin49.24%
EBITDA Margin-20.52%
Profit Margin-58.66%
ROE131.75%
ROA-47.99%
Growth
Revenue Growth-5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.83M USD
CapEx (TTM)83.00K USD
FCF Margin-29.81%
FCF Yield—
Net Debt-10.92M USD
Net Debt/EBITDA0.92
Balance Sheet
Debt/Equity-0.11
Current Ratio2.38
Quick Ratio1.05
Book Value/Sh0.8920 USD
Cash/Share1.115 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)8.500 USD
Target Range7.000 USD – 10.00 USD
# Analysts2
Ownership
Shares Out.12.10M
Float8.74M
Insiders21.50%
Institutions52.77%
Short Interest
Short Ratio10.2d
Short % Float11.11%
Short % Out.8.06%
Shares Short975.91K
Short (prev mo.)1.02M
Technical
SMA 506.018 USD
SMA 20010.41 USD
Beta0.84
S&P 52W Chg28.31%
Avg Vol (30d)—
Avg Vol (10d)71.46K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—